Publications by authors named "Liana Adam"

30Publications

A miRNA signature associated with human metastatic medullary thyroid carcinoma.

Endocr Relat Cancer 2013 Dec 14;20(6):809-23. Epub 2013 Oct 14.

Departments of Endocrine Neoplasia and Hormonal Disorders Experimental Therapeutics Urology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Department of Oncology, The University of Naples, Naples, Italy Department of Pathology, Centro Oncologico Fiorentino, Sesto Fiorentino, Florence, Italy Verna and Marrs McLean Department of Biochemistry and Molecular Biology Baylor College of Medicine, Houston, Texas, USA Department of Oncology, Istituto Toscano Tumori, Hospital of Prato, Prato, Italy Department of Gynecologic Oncology, Center for RNA Interference and Non-coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA Department of Endocrinology, University of Messina, Messina, Italy Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA Department of Internal Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-13-0357DOI Listing
December 2013

Plasma microRNA profiles for bladder cancer detection.

Urol Oncol 2013 Nov 3;31(8):1701-8. Epub 2012 Aug 3.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2012.06.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226073PMC
November 2013

Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.

Cancer Metastasis Rev 2009 Dec;28(3-4):335-44

Department of Urology, U.T. M.D. Anderson Cancer Center, P.O. Box 1373, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10555-009-9194-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915353PMC
December 2009

ADAM10 as a therapeutic target for cancer and inflammation.

Curr Pharm Des 2009 ;15(20):2288-99

Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY 11794, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/138161209788682442DOI Listing
October 2009

Therapeutic IMC-C225 antibody inhibits breast cancer cell invasiveness via Vav2-dependent activation of RhoA GTPase.

Clin Cancer Res 2008 Oct;14(19):6161-70

Department of Molecular and Cellular Oncology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-07-5288DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151536PMC
October 2008

Gefitinib reverses TRAIL resistance in human bladder cancer cell lines via inhibition of AKT-mediated X-linked inhibitor of apoptosis protein expression.

Cancer Res 2007 Feb;67(4):1430-5

Departments of Cancer Biology and Urology, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-06-1224DOI Listing
February 2007

Molecular correlates of gefitinib responsiveness in human bladder cancer cells.

Mol Cancer Ther 2007 Jan;6(1):277-85

Department of Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Unit 173, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://mct.aacrjournals.org/cgi/doi/10.1158/1535-7163.MCT-06
Publisher Site
http://dx.doi.org/10.1158/1535-7163.MCT-06-0513DOI Listing
January 2007

Schedule dependent efficacy of gefitinib and docetaxel for bladder cancer.

J Urol 2006 Aug;176(2):787-92

Department of Urology, University of Texas MD Anderson Cancer Center, Houston, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2006.03.072DOI Listing
August 2006

Uncoupling between epidermal growth factor receptor and downstream signals defines resistance to the antiproliferative effect of Gefitinib in bladder cancer cells.

Cancer Res 2005 Nov;65(22):10524-35

Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1536DOI Listing
November 2005

Clinical applications for targeted therapy in bladder cancer.

Urol Clin North Am 2005 May;32(2):239-46, vii

The University of Texas M.D. Anderson Cancer Center, Department of Urology, 1515 Holcombe Boulevard, Unit 1373, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2005.02.004DOI Listing
May 2005

Focus on bladder cancer.

Cancer Cell 2004 Aug;6(2):111-6

Department of Urology, The University of Texas M.D. Anderson Cancer Center, Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2004.08.002DOI Listing
August 2004

Heregulin and HER2 signaling selectively activates c-Src phosphorylation at tyrosine 215.

FEBS Lett 2003 May;543(1-3):76-80

Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0014-5793(03)00404-6DOI Listing
May 2003

Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1.

Nat Cell Biol 2002 Sep;4(9):681-90

Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncb838DOI Listing
September 2002

A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.

Nature 2002 Aug;418(6898):654-7

Department of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nature00889DOI Listing
August 2002

The role of mitogen-activated protein (MAP) kinase in breast cancer.

J Steroid Biochem Mol Biol 2002 Feb;80(2):239-56

Department of Medicine, Division of Endocrinology, University of Virginia Health System, P.O. Box 800379, Charlottesville, VA 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-0760(01)00189-3DOI Listing
February 2002

Differential regulation of components of the focal adhesion complex by heregulin: role of phosphatase SHP-2.

J Cell Physiol 2002 Feb;190(2):189-99

Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jcp.10054
Publisher Site
http://dx.doi.org/10.1002/jcp.10054DOI Listing
February 2002

Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.

Mol Endocrinol 2002 Jan;16(1):116-27

Department of Internal Medicine, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/mend.16.1.0748DOI Listing
January 2002